nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—RYR3—diaphragm—sarcoma	0.133	0.409	CbGeAlD
Dantrolene—CYP3A4—Thiotepa—sarcoma	0.109	0.458	CbGbCtD
Dantrolene—RYR1—larynx—sarcoma	0.0503	0.155	CbGeAlD
Dantrolene—CYP3A4—Mitoxantrone—sarcoma	0.0468	0.197	CbGbCtD
Dantrolene—CYP3A4—Vincristine—sarcoma	0.0322	0.136	CbGbCtD
Dantrolene—CYP3A4—Etoposide—sarcoma	0.0295	0.124	CbGbCtD
Dantrolene—RYR3—MFAP5-mediated ovarian cancer cell motility and invasiveness—PLCG1—sarcoma	0.0292	0.336	CbGpPWpGaD
Dantrolene—CYP3A4—Doxorubicin—sarcoma	0.0201	0.0848	CbGbCtD
Dantrolene—RYR3—myometrium—sarcoma	0.0161	0.0497	CbGeAlD
Dantrolene—RYR3—seminal vesicle—sarcoma	0.0146	0.0449	CbGeAlD
Dantrolene—RYR3—hematopoietic system—sarcoma	0.0138	0.0427	CbGeAlD
Dantrolene—RYR3—smooth muscle tissue—sarcoma	0.0122	0.0376	CbGeAlD
Dantrolene—RYR1—myometrium—sarcoma	0.0116	0.0357	CbGeAlD
Dantrolene—RYR3—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—sarcoma	0.0108	0.124	CbGpPWpGaD
Dantrolene—RYR3—uterus—sarcoma	0.0105	0.0323	CbGeAlD
Dantrolene—RYR3—lymphoid tissue—sarcoma	0.00974	0.0301	CbGeAlD
Dantrolene—RYR3—tendon—sarcoma	0.00916	0.0283	CbGeAlD
Dantrolene—RYR1—smooth muscle tissue—sarcoma	0.00874	0.027	CbGeAlD
Dantrolene—RYR3—testis—sarcoma	0.00758	0.0234	CbGeAlD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJA4—sarcoma	0.00757	0.0872	CbGpPWpGaD
Dantrolene—RYR1—uterus—sarcoma	0.0075	0.0231	CbGeAlD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CALD1—sarcoma	0.00734	0.0844	CbGpPWpGaD
Dantrolene—RYR1—tendon—sarcoma	0.00657	0.0203	CbGeAlD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJA4—sarcoma	0.00558	0.0643	CbGpPWpGaD
Dantrolene—RYR1—testis—sarcoma	0.00544	0.0168	CbGeAlD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CALD1—sarcoma	0.00541	0.0623	CbGpPWpGaD
Dantrolene—RYR1—liver—sarcoma	0.00514	0.0159	CbGeAlD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PLCG1—sarcoma	0.00377	0.0434	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ATF1—sarcoma	0.00358	0.0412	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PLCG1—sarcoma	0.00278	0.032	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATF1—sarcoma	0.00264	0.0304	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CREB1—sarcoma	0.00194	0.0223	CbGpPWpGaD
Dantrolene—CYP3A4—hematopoietic system—sarcoma	0.00173	0.00532	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—TP53—sarcoma	0.00158	0.0182	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CREB1—sarcoma	0.00143	0.0165	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	0.0014	0.0161	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	0.00103	0.0118	CbGpPWpGaD
Dantrolene—Hepatic failure—Epirubicin—sarcoma	0.00092	0.00262	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000919	0.00262	CcSEcCtD
Dantrolene—Chills—Etoposide—sarcoma	0.000915	0.0026	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000912	0.0026	CcSEcCtD
Dantrolene—Myalgia—Mitoxantrone—sarcoma	0.000909	0.00259	CcSEcCtD
Dantrolene—Discomfort—Mitoxantrone—sarcoma	0.000898	0.00256	CcSEcCtD
Dantrolene—Somnolence—Thiotepa—sarcoma	0.000897	0.00255	CcSEcCtD
Dantrolene—Anaphylactic shock—Vincristine—sarcoma	0.000895	0.00255	CcSEcCtD
Dantrolene—CYP3A4—liver—sarcoma	0.000894	0.00276	CbGeAlD
Dantrolene—Dyspepsia—Thiotepa—sarcoma	0.000888	0.00253	CcSEcCtD
Dantrolene—Phlebitis—Doxorubicin—sarcoma	0.000888	0.00253	CcSEcCtD
Dantrolene—Thrombophlebitis—Doxorubicin—sarcoma	0.000883	0.00251	CcSEcCtD
Dantrolene—Confusional state—Mitoxantrone—sarcoma	0.000879	0.0025	CcSEcCtD
Dantrolene—Decreased appetite—Thiotepa—sarcoma	0.000877	0.0025	CcSEcCtD
Dantrolene—Thrombocytopenia—Vincristine—sarcoma	0.000876	0.00249	CcSEcCtD
Dantrolene—Anaphylactic shock—Mitoxantrone—sarcoma	0.000871	0.00248	CcSEcCtD
Dantrolene—Decreased appetite—Dactinomycin—sarcoma	0.00087	0.00248	CcSEcCtD
Dantrolene—Fatigue—Thiotepa—sarcoma	0.00087	0.00248	CcSEcCtD
Dantrolene—Dysgeusia—Etoposide—sarcoma	0.00087	0.00247	CcSEcCtD
Dantrolene—Hyperhidrosis—Vincristine—sarcoma	0.000865	0.00246	CcSEcCtD
Dantrolene—Fatigue—Dactinomycin—sarcoma	0.000863	0.00246	CcSEcCtD
Dantrolene—Pain—Thiotepa—sarcoma	0.000863	0.00246	CcSEcCtD
Dantrolene—Constipation—Thiotepa—sarcoma	0.000863	0.00246	CcSEcCtD
Dantrolene—Back pain—Etoposide—sarcoma	0.000859	0.00244	CcSEcCtD
Dantrolene—Pain—Dactinomycin—sarcoma	0.000856	0.00244	CcSEcCtD
Dantrolene—Thrombocytopenia—Mitoxantrone—sarcoma	0.000853	0.00243	CcSEcCtD
Dantrolene—Anorexia—Vincristine—sarcoma	0.000853	0.00243	CcSEcCtD
Dantrolene—Hepatic failure—Doxorubicin—sarcoma	0.000851	0.00242	CcSEcCtD
Dantrolene—Tachycardia—Mitoxantrone—sarcoma	0.00085	0.00242	CcSEcCtD
Dantrolene—Cardiac failure—Epirubicin—sarcoma	0.000847	0.00241	CcSEcCtD
Dantrolene—Hyperhidrosis—Mitoxantrone—sarcoma	0.000842	0.0024	CcSEcCtD
Dantrolene—Feeling abnormal—Thiotepa—sarcoma	0.000831	0.00237	CcSEcCtD
Dantrolene—Anorexia—Mitoxantrone—sarcoma	0.000831	0.00236	CcSEcCtD
Dantrolene—Diplopia—Epirubicin—sarcoma	0.000827	0.00235	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000827	0.00235	CcSEcCtD
Dantrolene—Pain in extremity—Epirubicin—sarcoma	0.000827	0.00235	CcSEcCtD
Dantrolene—Feeling abnormal—Dactinomycin—sarcoma	0.000825	0.00235	CcSEcCtD
Dantrolene—Gastrointestinal pain—Thiotepa—sarcoma	0.000825	0.00235	CcSEcCtD
Dantrolene—Ill-defined disorder—Etoposide—sarcoma	0.000824	0.00234	CcSEcCtD
Dantrolene—Anaemia—Etoposide—sarcoma	0.000821	0.00234	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dactinomycin—sarcoma	0.000819	0.00233	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Vincristine—sarcoma	0.000815	0.00232	CcSEcCtD
Dantrolene—Insomnia—Vincristine—sarcoma	0.000809	0.0023	CcSEcCtD
Dantrolene—Urticaria—Thiotepa—sarcoma	0.000801	0.00228	CcSEcCtD
Dantrolene—Malaise—Etoposide—sarcoma	0.000801	0.00228	CcSEcCtD
Dantrolene—Abdominal pain—Thiotepa—sarcoma	0.000798	0.00227	CcSEcCtD
Dantrolene—Body temperature increased—Thiotepa—sarcoma	0.000798	0.00227	CcSEcCtD
Dantrolene—Leukopenia—Etoposide—sarcoma	0.000795	0.00226	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000794	0.00226	CcSEcCtD
Dantrolene—Body temperature increased—Dactinomycin—sarcoma	0.000792	0.00225	CcSEcCtD
Dantrolene—Abdominal pain—Dactinomycin—sarcoma	0.000792	0.00225	CcSEcCtD
Dantrolene—Cardiac failure—Doxorubicin—sarcoma	0.000784	0.00223	CcSEcCtD
Dantrolene—Decreased appetite—Vincristine—sarcoma	0.000778	0.00221	CcSEcCtD
Dantrolene—Somnolence—Mitoxantrone—sarcoma	0.000775	0.0022	CcSEcCtD
Dantrolene—Fatigue—Vincristine—sarcoma	0.000771	0.00219	CcSEcCtD
Dantrolene—Convulsion—Etoposide—sarcoma	0.000769	0.00219	CcSEcCtD
Dantrolene—Dyspepsia—Mitoxantrone—sarcoma	0.000767	0.00218	CcSEcCtD
Dantrolene—Hypertension—Etoposide—sarcoma	0.000767	0.00218	CcSEcCtD
Dantrolene—Pain—Vincristine—sarcoma	0.000765	0.00218	CcSEcCtD
Dantrolene—Constipation—Vincristine—sarcoma	0.000765	0.00218	CcSEcCtD
Dantrolene—Diplopia—Doxorubicin—sarcoma	0.000765	0.00218	CcSEcCtD
Dantrolene—Pain in extremity—Doxorubicin—sarcoma	0.000765	0.00218	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000765	0.00218	CcSEcCtD
Dantrolene—Decreased appetite—Mitoxantrone—sarcoma	0.000757	0.00216	CcSEcCtD
Dantrolene—Fatigue—Mitoxantrone—sarcoma	0.000751	0.00214	CcSEcCtD
Dantrolene—Discomfort—Etoposide—sarcoma	0.000747	0.00213	CcSEcCtD
Dantrolene—Constipation—Mitoxantrone—sarcoma	0.000745	0.00212	CcSEcCtD
Dantrolene—Pain—Mitoxantrone—sarcoma	0.000745	0.00212	CcSEcCtD
Dantrolene—Hypersensitivity—Thiotepa—sarcoma	0.000743	0.00212	CcSEcCtD
Dantrolene—Hypersensitivity—Dactinomycin—sarcoma	0.000738	0.0021	CcSEcCtD
Dantrolene—Gastrointestinal pain—Vincristine—sarcoma	0.000732	0.00208	CcSEcCtD
Dantrolene—Confusional state—Etoposide—sarcoma	0.000731	0.00208	CcSEcCtD
Dantrolene—Muscular weakness—Epirubicin—sarcoma	0.000729	0.00207	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—sarcoma	0.000725	0.00206	CcSEcCtD
Dantrolene—Asthenia—Thiotepa—sarcoma	0.000724	0.00206	CcSEcCtD
Dantrolene—Asthenia—Dactinomycin—sarcoma	0.000718	0.00204	CcSEcCtD
Dantrolene—Feeling abnormal—Mitoxantrone—sarcoma	0.000718	0.00204	CcSEcCtD
Dantrolene—Dysphagia—Epirubicin—sarcoma	0.000714	0.00203	CcSEcCtD
Dantrolene—Pruritus—Thiotepa—sarcoma	0.000714	0.00203	CcSEcCtD
Dantrolene—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000712	0.00203	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—sarcoma	0.00071	0.00202	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—sarcoma	0.000707	0.00201	CcSEcCtD
Dantrolene—Eosinophilia—Epirubicin—sarcoma	0.000707	0.00201	CcSEcCtD
Dantrolene—Body temperature increased—Vincristine—sarcoma	0.000707	0.00201	CcSEcCtD
Dantrolene—Abdominal pain—Vincristine—sarcoma	0.000707	0.00201	CcSEcCtD
Dantrolene—Hyperhidrosis—Etoposide—sarcoma	0.000701	0.00199	CcSEcCtD
Dantrolene—Urticaria—Mitoxantrone—sarcoma	0.000692	0.00197	CcSEcCtD
Dantrolene—Anorexia—Etoposide—sarcoma	0.000691	0.00197	CcSEcCtD
Dantrolene—Diarrhoea—Thiotepa—sarcoma	0.00069	0.00196	CcSEcCtD
Dantrolene—Abdominal pain—Mitoxantrone—sarcoma	0.000689	0.00196	CcSEcCtD
Dantrolene—Body temperature increased—Mitoxantrone—sarcoma	0.000689	0.00196	CcSEcCtD
Dantrolene—Diarrhoea—Dactinomycin—sarcoma	0.000685	0.00195	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—sarcoma	0.000675	0.00192	CcSEcCtD
Dantrolene—Dizziness—Thiotepa—sarcoma	0.000667	0.0019	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—sarcoma	0.000661	0.00188	CcSEcCtD
Dantrolene—Pollakiuria—Epirubicin—sarcoma	0.00066	0.00188	CcSEcCtD
Dantrolene—Hypersensitivity—Vincristine—sarcoma	0.000659	0.00188	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—sarcoma	0.000654	0.00186	CcSEcCtD
Dantrolene—Somnolence—Etoposide—sarcoma	0.000644	0.00183	CcSEcCtD
Dantrolene—Hypersensitivity—Mitoxantrone—sarcoma	0.000642	0.00183	CcSEcCtD
Dantrolene—Asthenia—Vincristine—sarcoma	0.000642	0.00183	CcSEcCtD
Dantrolene—Vomiting—Thiotepa—sarcoma	0.000641	0.00183	CcSEcCtD
Dantrolene—Drowsiness—Epirubicin—sarcoma	0.000637	0.00181	CcSEcCtD
Dantrolene—Vomiting—Dactinomycin—sarcoma	0.000637	0.00181	CcSEcCtD
Dantrolene—Rash—Thiotepa—sarcoma	0.000636	0.00181	CcSEcCtD
Dantrolene—Dermatitis—Thiotepa—sarcoma	0.000636	0.00181	CcSEcCtD
Dantrolene—Headache—Thiotepa—sarcoma	0.000632	0.0018	CcSEcCtD
Dantrolene—Rash—Dactinomycin—sarcoma	0.000631	0.0018	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—sarcoma	0.00063	0.00179	CcSEcCtD
Dantrolene—Renal failure—Epirubicin—sarcoma	0.000626	0.00178	CcSEcCtD
Dantrolene—Asthenia—Mitoxantrone—sarcoma	0.000625	0.00178	CcSEcCtD
Dantrolene—Fatigue—Etoposide—sarcoma	0.000625	0.00178	CcSEcCtD
Dantrolene—Pain—Etoposide—sarcoma	0.00062	0.00176	CcSEcCtD
Dantrolene—Constipation—Etoposide—sarcoma	0.00062	0.00176	CcSEcCtD
Dantrolene—Diarrhoea—Vincristine—sarcoma	0.000612	0.00174	CcSEcCtD
Dantrolene—Sweating—Epirubicin—sarcoma	0.000611	0.00174	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—sarcoma	0.000611	0.00174	CcSEcCtD
Dantrolene—Haematuria—Epirubicin—sarcoma	0.000607	0.00173	CcSEcCtD
Dantrolene—Nausea—Thiotepa—sarcoma	0.000599	0.00171	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—sarcoma	0.000597	0.0017	CcSEcCtD
Dantrolene—Diarrhoea—Mitoxantrone—sarcoma	0.000596	0.0017	CcSEcCtD
Dantrolene—Nausea—Dactinomycin—sarcoma	0.000595	0.00169	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—sarcoma	0.000593	0.00169	CcSEcCtD
Dantrolene—Dizziness—Vincristine—sarcoma	0.000592	0.00168	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—sarcoma	0.000589	0.00168	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—sarcoma	0.000579	0.00165	CcSEcCtD
Dantrolene—Urticaria—Etoposide—sarcoma	0.000576	0.00164	CcSEcCtD
Dantrolene—Haemoglobin—Epirubicin—sarcoma	0.000575	0.00164	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—sarcoma	0.000573	0.00163	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—sarcoma	0.000573	0.00163	CcSEcCtD
Dantrolene—Haemorrhage—Epirubicin—sarcoma	0.000572	0.00163	CcSEcCtD
Dantrolene—Hepatitis—Epirubicin—sarcoma	0.000572	0.00163	CcSEcCtD
Dantrolene—Vomiting—Vincristine—sarcoma	0.000569	0.00162	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—sarcoma	0.000565	0.00161	CcSEcCtD
Dantrolene—Rash—Vincristine—sarcoma	0.000564	0.00161	CcSEcCtD
Dantrolene—Dermatitis—Vincristine—sarcoma	0.000564	0.0016	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—sarcoma	0.000562	0.0016	CcSEcCtD
Dantrolene—Headache—Vincristine—sarcoma	0.00056	0.00159	CcSEcCtD
Dantrolene—Vomiting—Mitoxantrone—sarcoma	0.000554	0.00158	CcSEcCtD
Dantrolene—Visual impairment—Epirubicin—sarcoma	0.000551	0.00157	CcSEcCtD
Dantrolene—Rash—Mitoxantrone—sarcoma	0.000549	0.00156	CcSEcCtD
Dantrolene—Dermatitis—Mitoxantrone—sarcoma	0.000549	0.00156	CcSEcCtD
Dantrolene—Headache—Mitoxantrone—sarcoma	0.000546	0.00155	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—sarcoma	0.000534	0.00152	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—sarcoma	0.000532	0.00151	CcSEcCtD
Dantrolene—Nausea—Vincristine—sarcoma	0.000531	0.00151	CcSEcCtD
Dantrolene—Flushing—Epirubicin—sarcoma	0.000531	0.00151	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—sarcoma	0.000529	0.00151	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—sarcoma	0.000529	0.00151	CcSEcCtD
Dantrolene—Asthenia—Etoposide—sarcoma	0.00052	0.00148	CcSEcCtD
Dantrolene—Nausea—Mitoxantrone—sarcoma	0.000518	0.00147	CcSEcCtD
Dantrolene—Chills—Epirubicin—sarcoma	0.000513	0.00146	CcSEcCtD
Dantrolene—Pruritus—Etoposide—sarcoma	0.000513	0.00146	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—sarcoma	0.00051	0.00145	CcSEcCtD
Dantrolene—Erythema—Epirubicin—sarcoma	0.000498	0.00142	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—sarcoma	0.000496	0.00141	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—sarcoma	0.000491	0.0014	CcSEcCtD
Dantrolene—Tension—Epirubicin—sarcoma	0.000488	0.00139	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—sarcoma	0.000487	0.00139	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—sarcoma	0.000483	0.00138	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000483	0.00556	CbGpPWpGaD
Dantrolene—Back pain—Epirubicin—sarcoma	0.000481	0.00137	CcSEcCtD
Dantrolene—Dizziness—Etoposide—sarcoma	0.000479	0.00136	CcSEcCtD
Dantrolene—Chills—Doxorubicin—sarcoma	0.000475	0.00135	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—sarcoma	0.000469	0.00133	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—sarcoma	0.000462	0.00131	CcSEcCtD
Dantrolene—Vomiting—Etoposide—sarcoma	0.000461	0.00131	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—sarcoma	0.000461	0.00131	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—sarcoma	0.00046	0.00131	CcSEcCtD
Dantrolene—Rash—Etoposide—sarcoma	0.000457	0.0013	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—sarcoma	0.000457	0.0013	CcSEcCtD
Dantrolene—Headache—Etoposide—sarcoma	0.000454	0.00129	CcSEcCtD
Dantrolene—Tension—Doxorubicin—sarcoma	0.000452	0.00129	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—sarcoma	0.000451	0.00128	CcSEcCtD
Dantrolene—Malaise—Epirubicin—sarcoma	0.000449	0.00128	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—sarcoma	0.000447	0.00127	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—sarcoma	0.000446	0.00127	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—sarcoma	0.000446	0.00127	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—sarcoma	0.000434	0.00124	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—sarcoma	0.000431	0.00123	CcSEcCtD
Dantrolene—Nausea—Etoposide—sarcoma	0.00043	0.00122	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—sarcoma	0.00043	0.00122	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—sarcoma	0.000427	0.00122	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—sarcoma	0.000426	0.00121	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—sarcoma	0.000424	0.00121	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—sarcoma	0.000419	0.00119	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—sarcoma	0.000415	0.00118	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—sarcoma	0.000414	0.00118	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—sarcoma	0.000412	0.00117	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—sarcoma	0.00041	0.00117	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—sarcoma	0.000406	0.00116	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—sarcoma	0.000399	0.00114	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—sarcoma	0.000398	0.00113	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—sarcoma	0.000398	0.00113	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—sarcoma	0.000396	0.00113	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—sarcoma	0.000393	0.00112	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—sarcoma	0.000392	0.00112	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—sarcoma	0.000387	0.0011	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—sarcoma	0.000387	0.0011	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—sarcoma	0.000383	0.00109	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—sarcoma	0.000379	0.00108	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—sarcoma	0.000376	0.00107	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00037	0.00105	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—sarcoma	0.000368	0.00105	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—sarcoma	0.000367	0.00105	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—sarcoma	0.000367	0.00104	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—sarcoma	0.000363	0.00103	CcSEcCtD
Dantrolene—Somnolence—Epirubicin—sarcoma	0.000361	0.00103	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—sarcoma	0.000358	0.00102	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—sarcoma	0.000358	0.00102	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—sarcoma	0.000353	0.001	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—sarcoma	0.00035	0.000997	CcSEcCtD
Dantrolene—Pain—Epirubicin—sarcoma	0.000347	0.000989	CcSEcCtD
Dantrolene—Constipation—Epirubicin—sarcoma	0.000347	0.000989	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000342	0.000975	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—sarcoma	0.00034	0.000967	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—sarcoma	0.000335	0.000953	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—sarcoma	0.000334	0.000951	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—sarcoma	0.000332	0.000945	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—sarcoma	0.000331	0.000942	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—sarcoma	0.000327	0.00093	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—sarcoma	0.000324	0.000922	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—sarcoma	0.000323	0.000918	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—sarcoma	0.000321	0.000915	CcSEcCtD
Dantrolene—Pain—Doxorubicin—sarcoma	0.000321	0.000915	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—sarcoma	0.000321	0.000914	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—sarcoma	0.000321	0.000914	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—sarcoma	0.00031	0.000881	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—sarcoma	0.000307	0.000875	CcSEcCtD
Dantrolene—Hypersensitivity—Epirubicin—sarcoma	0.000299	0.000852	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—sarcoma	0.000299	0.00085	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—sarcoma	0.000297	0.000846	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—sarcoma	0.000297	0.000846	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—sarcoma	0.000291	0.000829	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—sarcoma	0.000287	0.000818	CcSEcCtD
Dantrolene—Diarrhoea—Epirubicin—sarcoma	0.000278	0.000791	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—sarcoma	0.000277	0.000788	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—sarcoma	0.00027	0.000767	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—sarcoma	0.000269	0.000764	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—sarcoma	0.000266	0.000757	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—sarcoma	0.000258	0.000735	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—sarcoma	0.000257	0.000732	CcSEcCtD
Dantrolene—Rash—Epirubicin—sarcoma	0.000256	0.000729	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—sarcoma	0.000256	0.000728	CcSEcCtD
Dantrolene—Headache—Epirubicin—sarcoma	0.000254	0.000724	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—sarcoma	0.000249	0.000707	CcSEcCtD
Dantrolene—Nausea—Epirubicin—sarcoma	0.000241	0.000687	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—sarcoma	0.000239	0.00068	CcSEcCtD
Dantrolene—Rash—Doxorubicin—sarcoma	0.000237	0.000674	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—sarcoma	0.000237	0.000674	CcSEcCtD
Dantrolene—Headache—Doxorubicin—sarcoma	0.000235	0.00067	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—sarcoma	0.000223	0.000635	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000217	0.0025	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO2—sarcoma	3.57e-05	0.000411	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HBA1—sarcoma	3.55e-05	0.000409	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCG1—sarcoma	3.03e-05	0.000349	CbGpPWpGaD
